{
    "title": "NHS chiefs' U-turn over life-extending ovarian cancer drug: Officials finally relent and allow women access to treatment that can increase lives by several months",
    "url": "https://www.dailymail.co.uk/health/article-3355351/NHS-chiefs-U-turn-life-extending-ovarian-cancer-drug.html",
    "date": "2015-12-11",
    "keywords": [
        "cancer",
        "drug",
        "access",
        "treatment",
        "disease",
        "year",
        "decision",
        "health",
        "drugolaparib",
        "chemotherapy",
        "average",
        "share",
        "use",
        "england",
        "price",
        "prostate",
        "need",
        "london",
        "faultsit",
        "brca",
        "gene",
        "joliethe",
        "funding",
        "draft",
        "fury",
        "watchdog",
        "nice",
        "class",
        "quarter",
        "breakthrough",
        "blood",
        "test",
        "dealer",
        "father",
        "son",
        "misuse",
        "hidden",
        "menopause",
        "prolapse",
        "article",
        "form",
        "britain",
        "firm",
        "europe",
        "december",
        "trialsit",
        "france",
        "sweden",
        "statesbut",
        "wrangling",
        "pill",
        "body",
        "risk",
        "xtandi",
        "stage",
        "cent",
        "chance",
        "killer",
        "illness",
        "month",
        "astrazeneca",
        "brand",
        "name",
        "lynparza",
        "group",
        "parp",
        "weakness",
        "tumour",
        "cellsprofessor",
        "workman",
        "institute",
        "research",
        "easing",
        "today",
        "bottleneck",
        "professor",
        "university",
        "college",
        "olaparib"
    ],
    "category": [
        "health"
    ]
}